secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0000896264-25-000213
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20
------------------------------------------------------------------------------

- Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.
- Direct selling active customers down 14% to 388,000; Hiya subscribers 193,400 (down 3% sequentially).
- FY25 guidance cut sharply: diluted EPS $0.78 (prev $1.50-$2.20); adj. diluted EPS $1.73 (prev $2.35-$3.00).
- Effective tax rate jumped to 65% from 45%, causing ~$7.6M income tax expense adjustment in Q3.
- Company expects $4.7M restructuring charge in Q4 to align costs with sales; cash $145M, no debt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/0000896264-25-000213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/usna-20251022.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer